Today is: April 17, 2011

Evaluate Your Case Today

Calcagno & Associates

900 South Avenue, 3rd Floor
Staten Island, NY, 10314
Phone: 1-800-WE-FIGHT
             (718) 568-3585

By appointment only

Battery Place
New York, NY, 10004
Phone: (800) 933-4448

Grand Concourse Bronx, NY, 10451 Phone: (718) 933-4448

Bay Parkway Brooklyn, NY, 11214 Phone: (800) 487-6837

Name (First & Last)
DOB (Victims Date of Birth)


Email Address





Message about your case


Elidel Linked to Skin Cancer and Lymphoma

Elidel (pimecrolimus cream) is a popular cream that is used to treat mild to moderate atopic dermatitis, a form of eczema. Elidel is an immunomodulator which suppresses the body’s immune system to treat the symptoms of itchiness, redness and cracked skin that is commonly associated with atopic dermatitis and eczema. Elidel is also commonly prescribed off-label for the treatment of psoriasis.

Elidel – Putting our Children at Risk

Infants and children make up a large percentage of atopic dermatitis eczema cases in the United States. According to the FDA, 12.7 percent of all Elidel prescriptions were prescribed for children between 1 and 2 years old. Elidel is only approved for use in children aged two and up.

FDA Elidel Warning

After Elidel was approved in December 2001 reports of cancer among patients using the cream began to surface. On January 19, 2006 the fears that Elidel could be linked to cancer were confirmed when the FDA issued a black box warning that said the cream may be linked with lymphoma and skin cancer. A black box warning is the strongest warning the FDA can issue.

The FDA warning also said that Elidel should only be used for a short time, and not for continuous long-term use which was common amongst atopic dermatitis, eczema and psoriasis patients. The FDA also said that Elidel cream should only be prescribed as a last resort. Elidel should not be the first prescription treatment used to treat atopic dermatitis and should only be prescribed when other medications failed.

Do not use Elidel under any circumstances if:

Lymphoma – A Serious form of Cancer Potentially Linked to Elidel

Lymphoma is a general term for a group of blood cancers that originate in the lymphatic system, usually in the lymph nodes. Lymphomas are divided into two major categories: Hodgkin lymphoma and all other lymphomas, called non-Hodgkin lymphomas.

Lymphomas comprise approximately 53 percent of the blood cancers that occur each year.

Lymphomas are the result of lymphocyte (a type of white blood cell) becoming malignant and multiplying. The multiplying malignant cells eventually crowd out healthy cells and creating tumors that enlarge the lymph nodes or other parts of the immune system. Hodgkin lymphoma and non-Hodgkin lymphoma differ from each other in their pathologic features, epidemiology, sites of involvement, clinical behavior, and treatment. Hodgkin lymphoma is more curable than non-Hodgkin lymphoma, although tremendous advances are being made on treating that form of the disease as well.

Squamous Cell Carcinoma – A Serious Skin Cancer Potentially Linked to Elidel

Squamous cell carcinoma is a form of cancer that may occur in many different organs, but commonly develops on the skin. This type of cancer is characterized by red, scaly skin that becomes an open sore. The squamous cell is found in the outer layers of the skin (the epidermis) and is a type of Keratinocyte (a cell that makes the protein Keratin).

If squamous cell carcinoma on the skin is not treated it can penetrate underlying tissues and spread to other parts of the body. In these cases the cancer can reach vital organs and can become fatal. Squamous cell carcinomas that spread or metastasize commonly develop on areas of skin that are chronically inflamed, mucous membranes or the lips.

Legal Help for Elidel Side Effects Victims

If you or a loved one was prescribed Elidel and developed Lymphoma, skin cancer or any other side effect you may have valuable legal rights. Contact us today to have an experienced attorney evaluate your case for absolutely free. To request a free case evaluation, please complete the submission form on this page or call 1(800)WE-FIGHT.

Return to Defective Drugs Listing


Keywords | Articles | Locations | Coupons |